表达IL-10的CAR-T细胞抵抗功能障碍,并提供固体瘤和转移的持续清除
Yang Zhao1,2, Jiangqing Chen3, Massimo Andreatta4,5
1Institute of Bioengineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Nature biotechnology
|January 3, 2024
概括
工程化仿真抗原受体 (CAR) T细胞分泌互白素-10 (IL-10) 克服了固体瘤的挑战. 这种代谢装甲方法增强T细胞功能,导致瘤根除和持久免疫力.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞工程 细胞工程
背景情况:
- 化学抗原受体 (CAR) T细胞疗法在血液癌症中表现有前途,但由于T细胞疲劳和功能障碍,在固体瘤中面临挑战.
- 瘤微环境有助于CAR T细胞功能障碍,限制治疗疗效.
- 克服T细胞功能障碍对于扩大CAR T细胞治疗到固体恶性瘤至关重要.
研究的目的:
- 设计CAR-T细胞以抵抗瘤微环境中的功能障碍.
- 为了增强CAR T细胞代谢功能和对固体瘤治疗的效应器能力.
- 评估在临床前癌症模型中代谢装甲的CAR T细胞的疗效.
主要方法:
- 汽车T细胞被设计为分泌互白素-10 (IL-10) 进行代谢装甲.
- 在瘤微环境中的IL-10分泌CAR T细胞中评估了线粒体结构,功能和氧化酸化.
- 在结肠癌,乳腺癌,黑色素瘤和胰腺癌的合成和异种移植小鼠模型中评估了治疗疗效.
主要成果:
- IL-10分泌的CAR T细胞保持了线粒体的完整性,并增强了氧化酸化.
- 改造的CAR T细胞表现出增加的增殖和效应器功能,导致已建立的固体瘤和转移性癌症的完全回归.
- IL-10 CAR T 细胞诱导了持久的,类似干细胞的记忆反应,提供了对瘤复发的保护.
结论:
- 通过IL-10分泌来对CAR-T细胞进行代谢装甲是抵消固体瘤中T细胞功能障碍的可行策略.
- 这种方法带来了强大的抗瘤活性,包括根除既定和转移性癌症.
- 改造的CAR T细胞建立了长期的免疫保护,为固体瘤免疫疗法提供了可通用的平台.
相关概念视频
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Cytotoxic T Cells-mediated Immune Response
923
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
923


